2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
Michael D Serby, Hongyu Zhao, Bruce G Szczepankiewicz, Christi Kosogof, Zhili Xin, Bo Liu, Mei Liu, Lissa T J Nelson, Wiweka Kaszubska, H Douglas Falls, Verlyn Schaefer, Eugene N Bush, Robin Shapiro, Brian A Droz, Victoria E Knourek-Segel, Thomas A Fey, Michael E Brune, David W A Beno, Theresa M Turner, Christine A Collins, Peer B Jacobson, Hing L Sham, Gang Liu
Index: J. Med. Chem. 49(8) , 2568-78, (2006)
Full Text: HTML
Abstract
Ghrelin, a gut-derived orexigenic hormone, is an endogenous ligand of the growth hormone secretagogue receptor (GHS-R). Centrally administered ghrelin has been shown to cause hunger and increase food intake in rodents. Inhibition of ghrelin actions with ghrelin antibody, peptidyl GHS-R antagonists, and antisense oligonucleosides resulted in weight loss and food intake decrease in rodents. Here we report the effects of GHS-R antagonists, some of which were potent, selective, and orally bioavailable. A structure-activity relationship study led to the discovery of 8a, which was effective in decreasing food intake and body weight in several acute rat studies.
Related Compounds
Related Articles:
2015-12-01
[Neuropharmacology 99 , 422-31, (2015)]
2015-01-01
[Eur. J. Med. Chem. 96 , 269-80, (2015)]
2015-03-01
[Acta Crystallogr. C Struct. Chem. 71(Pt 3) , 229-38, (2015)]
2009-03-01
[Anal. Bioanal. Chem 393(6-7) , 1709-18, (2009)]
2007-06-01
[Antimicrob. Agents Chemother. 51(6) , 2268-73, (2007)]